Navigation auf uzh.ch
Research in the Department of Cranio-Maxillofacial Surgery covers head and neck oncology, computer assisted surgery, photodynamic therapy, and oral biotechnology & bioengineering.
The projects of the latter one are epigenetic active small chemicals to be applied for bone regeneration, treatment of bone defects in inflammation-compromised situations, adiposity, and even male contraception.
The other major field of oral biotechnology & bioengineering is additive manufacturing of bone substitutes with the final aim to provide our patients with osteoconductive bone substitutes from calcium phosphate and Bioglass, and to realize the use of personalized bone substitutes for our patients.
The project on additive manufacturing of bone substitutes is funded by the Swiss National Science Foundation and includes partners from the University of Applied Science (Muttenz, Switzerland) and the PolyU (Hong Kong). After we have unraveled the microarchitecture of lattice structures and pore-based structures to yield in accelerated bone ingrowth and defect bridging, we now shift towards a better understanding of the biology of osteoconduction as a major driving force for bone regeneration and repair.
A third project of oral biotechnology & bioengineering is funded by a Bundesstipendium and deals with the preservation and regeneration of the pulp to keep teeth alive, to postpone tooth loss, and replacement by dental implants.
Computer assisted surgery is another focus in our department. Here we want to optimize the digital planning of operations and move on towards automation of planning and quality control. Finally, we want to offer our patients patient-specific implants and osteosynthesis materials.
Photodynamic therapy is a promising treatment for medication-related osteonecrosis of the jaw (MRONJ). MRONJ is a severe adverse drug reaction, manifested in a progressive irreversible bone destruction in the maxillofacial region, associated with discomfort and pain for the patients.